A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Clinical trial NCT05109234 · COMPLETED

Trial details

NCT number: NCT05109234
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Childhood Absence Epilepsy Juvenile Absence Epilepsy

Start date: 2022-03-30
Primary completion: 2025-03-18
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.